APL-1, an altered peptide ligand derived from human heat-shock protein 60, selectively induces apoptosis in activated CD4+ CD25+ T cells from peripheral blood of rheumatoid arthritis patients-Reference-Cited by-同舟云学术

APL-1, an altered peptide ligand derived from human heat-shock protein 60, selectively induces apoptosis in activated CD4+ CD25+ T cells from peripheral blood of rheumatoid arthritis patients

Published:2013-12 Issue:4 Volume:17 Page:1075-1083
ISSN:1567-5769
Container-title:International Immunopharmacology
language:en
Short-container-title:International Immunopharmacology

Author:

Barberá Ariana,Lorenzo Noraylis,Garrido Greta,Mazola Yuliet,Falcón Viviana,Torres Ana María,Hernández María Isabel,Hernández María Victoria,Margry Bram,de Groot A. Marit,van Roon Joel,van der Zee Ruurd,Broere Femke,van Eden Willem,Padrón Gabriel,del Carmen Domínguez María

Funder

L'Oreal/UNESCO

Dutch Arthritis Foundation

Innovation Oriented Programme Genomics (IOP)

Publisher

Elsevier BV

Subject

Pharmacology,Immunology,Immunology and Allergy

Reference47 articles.

1. Rheumatoid arthritis;Pap,2002

2. The genetics revolution and the assault on rheumatoid arthritis;Seldin;Arthritis Rheum,1999

3. Association of MHC and rheumatoid arthritis. Association of RA with HLA-DR4: the role of repertoire selection;Roudier;Arthritis Res,2000